clinical trial · NCT06591806
An Observational Study in Children and Adults With Stargardt Disease
Stargardt Disease
brief summary
This multicenter, prospective, longitudinal, observational study in approximately 80 subjects with Stargardt disease secondary to biallelic mutations in the ABCA4 gene (STGD1) aims to evaluate prognostic factors of disease progression, and to further characterize the patient population for future clinical studies.
started
May 1, 2024
primary completion
Jun 30, 2027
completion
Jun 30, 2027
last updated
Aug 28, 2025
official title
A Multicenter, Prospective, Longitudinal, Observational Study in Children and Adults With Stargardt Disease Related Atrophy Secondary to Biallelic Mutations in the ABCA4 Gene
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol